U.S. Markets closed

Pfizer’s Vaccines: A Look at Their Market Performance

Daniel Collins
Pfizer’s Vaccines: A Look at Their Market Performance

An Overview of Pfizer’s Oncology and Vaccine Business(Continued from Prior Part)Vaccine revenue In the first nine months of this year, Pfizer’s (PFE) vaccines sales grew ~7% YoY (year-over-year) to $4.